Thu, October 13, 2022

Matthew Harrison Maintained (BGNE) at Buy with Increased Target to $295 on, Oct 13th, 2022

Matthew Harrison of Morgan Stanley, Maintained "BeiGene, Ltd." (BGNE) at Buy with Increased Target from $290 to $295 on, Oct 13th, 2022.

Matthew has made no other calls on BGNE in the last 4 months.



There is 1 other peer that has a rating on BGNE. Out of the 1 peers that are also analyzing BGNE, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Xiling Chen of "JP Morgan" Initiated at Buy and Held Target at $296 on, Tuesday, August 9th, 2022